Optimizing clotting factor replacement therapy in hemophilia: A global need

By Srivastava Alok  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 229-230

Maney Publishing

Access to resources Recommend Favorite

Surveillance for Factor VIII Inhibitor Development in the Canadian Hemophilia A Population Following the Widespread Introduction of Recombinant Factor VIII Replacement Therapy

By Giles A.R.   Rivard G.E.   Teitel J.   Walker I.  

Transfusion and Apheresis Science, Vol. 19, Iss. 2, 1998-06 ,pp. : 139-148

Elsevier

Access to resources Recommend Favorite

Surveillance for Factor VIII Inhibitor Development in the Canadian Hemophilia A Population Following the Widespread Introduction of Recombinant Factor VIII Replacement Therapy

By Giles A.R.   Rivard G.E.   Teitel J.   Walker I.  

Transfusion Science, Vol. 19, Iss. 2, 1998-06 ,pp. : 139-148

Elsevier

Access to resources Recommend Favorite

Gene Therapy for Immunologic Tolerance: Using Bone Marrow-Derived Cells to Treat Autoimmunity and Hemophilia

By  

Current Stem Cell Research & Therapy, Vol. 6, Iss. 1, 2011-03 ,pp. : 38-43

Bentham Science Publishers

Access to resources Recommend Favorite

A common G10430A mutation (Gly 60 Ser) in the factor IX gene describes the presence of moderate and mild hemophilia B in the majority of the Gujarati population

By Quadros Leera   Ghosh Kanjaksha   Shetty Shrimati  

Annals of Hematology, Vol. 86, Iss. 5, 2007-05 ,pp. : 377-379

Springer Publishing Company

Access to resources Recommend Favorite